| |
|
|
|
Aytu Bioscience Inc  
|
|
7.89 -0.46 (-0.06%) |
01-27 16:00 |
|
Open: |
7.7902 |
Pre close: |
8.35 |
Target:
|
10.15
|
|
High: |
8.32 |
Low: |
7.69 |
Resistance:
|
8.69
10.15
|
|
Volume: |
681,844 |
Market Cap: |
136M |
Support:
|
6.96
5.89
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.10
 |
MACD |
MACD(12,26):
|
0.26 |
|
MA(20): |
7.14  |
Signal(12,26,9): |
0.06 |
|
MA(100): |
9.33 |
Stochastic Oscillator |
%K(14,3):
|
84.41 |
|
MA(250): |
11.65 |
%D(3): |
87.73 |
|
Average Volume(K) |
3-Month: |
88189
|
52-Week |
High:
|
29.90 |
|
10-Days: |
59813 |
Low: |
3.40 |
|
RSI |
RSI(14):
|
56.07 |
Change(%): |
2.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.810 |
Return on Equity (ttm) |
-27.8 |
Shares Out. (M) |
17.25 |
|
EPS Est. Current Year |
-29.400 |
Return on Assets (ttm) |
-13.8 |
Shares Float (M) |
10.59 |
|
EPS Est. Next Year |
-12.800 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.37 |
|
EPS Est. Next Quarter |
-7.400 |
Qtrly Rev. Growth |
839.0 |
% Held by Institutions |
25.98 |
|
Forward EPS |
-3.480 |
Gross Profit (p.s.) |
1.164 |
Shares Short (K) |
802 |
|
Book Value (p.s.) |
7.240 |
EBITDA (p.s.) |
-0.672 |
P/E |
-4.36 |
|
Sales Per Share |
2.302 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.09 |
|
Profit Margin |
-32.73 |
Operating Cash Flow
(M) |
-33.36 |
P/S |
3.43 |
|
Operating Margin |
-47.99 |
Levered Free Cash Flow
(M) |
-16.99 |
P/CF |
-4.08 |
|
|
|
|
|
|
